Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Dynamics of Immune Reconstitution after Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide Compared to Classical Immunosuppression with ATG

Mariana Nassif Kerbauy, Fernanda Agostini Rocha, Leonardo Javier Arcuri, Priscila Silva Cunegundes, Clarisse MARTINS Machado, Andreza Feitosa Ribeiro, Lucila Nassif Kerbauy, Luciana Cavalheiro Marti, Nelson Hamerschlak

Blood (2023) 142 (Supplement 1): 3574.

https://doi.org/10.1182/blood-2023-188052

Published: 2023

Journal Articles

Real World Data on Treatment of Acute Myeloid Leukemia (AML) in a Private Healthcare Institution in Brazil, a Low-Middle Income Country - Importance of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Carolina Perrone Marques, Carolina Leme de Moura Pereira, Jade Zezzi Nascimento, Tarcila Santos Datoguia, Felipe Galvão Batista Chaves, Juliana Dall Agnol Rocha, Amanda Inácio Dias Ennes, Eduardo Cerello Chapchap, Paulo Vidal Campregher, Leonardo Javier Arcuri, Andreza Feitosa Ribeiro, Nelson Hamerschlak, Fabio P. S. Santos

Blood (2023) 142 (Supplement 1): 7440.

https://doi.org/10.1182/blood-2023-191152

Published: 2023

Journal Articles

Evaluation of the Impact of the Disease Risk Index and Pre-Transplant Measurable Residual Disease By Flow Cytometry As Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia

Carolina Perrone Marques, Ana Carolina de Almeida Silveira, Jade Zezzi, Felipe Galvão Batista Chaves, Juliana Dall'Agnol da Rocha, Renata Leati Stanzione, Mariana Nassif Kerbauy, Nelson Hamerschlak, Fabio P. S. Santos, Leonardo Javier Arcuri, Andreza Feitosa Ribeiro

Blood (2023) 142 (Supplement 1): 7438.

https://doi.org/10.1182/blood-2023-190786

Published: 2023

Journal Articles

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Leonardo Javier Arcuri, Fabio Pires de Souza Santos, Lucila Kerbauy, Mariana Nassif Kerbauy, Andreza Feitosa Ribeiro, Nelson Hamerschlak

Blood (2022) 140 (Supplement 1): 4767–4769.

https://doi.org/10.1182/blood-2022-156282

Published: 2022

Journal Articles

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Naveed Ali, MD, Ana Carolina Pires de Rezende, MD, Folashade Otegbeye, MBBChir,MPH, Mariana Nassif Kerbauy, MD, Brenda W. Cooper, MD, David Mansur, MD, Gisele Pereira, PhD, Roberto Sakuraba, MD, Benjamin K. Tomlinson, MD, Kirsten M Boughan, DO, Cinthya Correa Silva, MD, Leland Metheny, III, MD, Andreza Feitosa Ribeiro, MD, Molly M Gallogly, MDPhD, Ehsan Malek, MD, EDuardo Weltman, MD, Marcos de Lima, MD, Nelson Hamerschlak, MD PhD, Paolo F Caimi, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142197

Published: 2020

Journal Articles

High Incidence of Neurological Complications in Patients with Sickle Anemia Disease Undergoing Related Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Early Diagnosis and Treatment Can Chance the Prognosis

Ricardo Helman, Juliana Folloni Fernandes, PhD, Michelli Silva Diniz, RN, Fabio R. Kerbauy, MD PhD, Lucila Nassif Kerbauy, Eduardo Cerello Chapchap, Melina Brumatti, Nathalia da Silva Halley Neves, Alessandra Prandini Azambuja, Jose Mauro Kutner, MD PhD, Andreza Feitosa Ribeiro, MD PhD, Nelson Hamerschlak, MD PhD

Blood (2014) 124 (21): 5941.

https://doi.org/10.1182/blood.V124.21.5941.5941

Published: 2014

Journal Articles

The Clinical and Therapeutic Drug Monitoring of Oral and Intravenous Busulfan in Patients with Acute Leukemia That Underwent to Stem Cell Transplantation with a Test Dose of Busulfan

Iracema Esteves, PhD, Juliana F Fernandes, MD, Andreza Feitosa Ribeiro, MD PhD, Fabio P S Santos, MD, Ricardo Helman, MD, Claudio Castro Junior, MD, Vinicius R. P. Mattos, MD, Andrea Tiemi Kondo, MD, Adriana Seber, MD, Jose Salvador Rodrigues Oliveira, PhD, José Carlos Barros, MD PhD, Vergilio Antonio Renzi Colturato, MD, Nelson Hamerschlak, MD PhD, Fabio Rodrigues Kerbauy, PhD

Blood (2014) 124 (21): 5841.

https://doi.org/10.1182/blood.V124.21.5841.5841

Published: 2014

NARROW

Dynamics of Immune Reconstitution after Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide Compared to Classical Immunosuppression with ATG

Real World Data on Treatment of Acute Myeloid Leukemia (AML) in a Private Healthcare Institution in Brazil, a Low-Middle Income Country - Importance of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Evaluation of the Impact of the Disease Risk Index and Pre-Transplant Measurable Residual Disease By Flow Cytometry As Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

High Incidence of Neurological Complications in Patients with Sickle Anemia Disease Undergoing Related Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Early Diagnosis and Treatment Can Chance the Prognosis

The Clinical and Therapeutic Drug Monitoring of Oral and Intravenous Busulfan in Patients with Acute Leukemia That Underwent to Stem Cell Transplantation with a Test Dose of Busulfan

Email alerts

ASH Publications

American Society of Hematology

Dynamics of Immune Reconstitution after Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide Compared to Classical Immunosuppression with ATG

Real World Data on Treatment of Acute Myeloid Leukemia (AML) in a Private Healthcare Institution in Brazil, a Low-Middle Income Country - Importance of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Evaluation of the Impact of the Disease Risk Index and Pre-Transplant Measurable Residual Disease By Flow Cytometry As Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

High Incidence of Neurological Complications in Patients with Sickle Anemia Disease Undergoing Related Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Early Diagnosis and Treatment Can Chance the Prognosis

The Clinical and Therapeutic Drug Monitoring of Oral and Intravenous Busulfan in Patients with Acute Leukemia That Underwent to Stem Cell Transplantation with a Test Dose of Busulfan

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only